EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-130.28M
↓ 252% below average
Average (9y)
$-36.99M
Historical baseline
Range
High:$10.14M
Low:$-130.28M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-130.28M | -8001.9% |
| 2023 | $-1.61M | +97.6% |
| 2022 | $-67.16M | -33.6% |
| 2021 | $-50.25M | -239.6% |
| 2020 | $-14.80M | +74.0% |
| 2019 | $-56.91M | -158.5% |
| 2018 | $-22.02M | -6.7% |
| 2017 | $-20.64M | -25.6% |
| 2016 | $-16.43M | -262.1% |
| 2015 | $10.14M | - |